Patent · US Active

RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

US8173617B2 · kind B2 · utility

31Cited by

2References

17Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Abbot F. Clark · Arlington, US
Wan-Heng Wang · Fort Worth, US
Loretta McNatt · Hurst, US
Jon E. Chatterton · Fort Worth, US

Key dates

Filing date	Apr 12, 2011
Grant date	May 8, 2012
Priority date	—
Expiry date	Apr 12, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/351
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

RNA interference is provided for inhibition of Frizzled Related Protein-1 mRNA expression, in particular, for treating patients having glaucoma or at risk of developing glaucoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.